Tokushima, Japan

Setsuko Takegata


Average Co-Inventor Count = 8.2

ph-index = 3

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 1982-2000

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Setsuko Takegata

Introduction

Setsuko Takegata is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of interleukin 1.beta. (IL-1.beta.) and its derivatives. With a total of 8 patents to his name, Takegata's work has had a substantial impact on medical science.

Latest Patents

Among his latest patents are groundbreaking innovations related to IL-1.beta. and its derivatives. One notable patent focuses on a homogeneous interleukin 1.beta. (IL-1.beta.) and its derivative, which features a modified amino acid sequence. This patent also includes a gene coding for the derivative, a medical composition comprising the derivative as a pharmaceutically effective component, and a medicinal use of homogeneous IL-1.beta. and its derivative. Another significant patent involves DNA encoding an interleukin IL-1.beta. mutant, further emphasizing the importance of his research in this area.

Career Highlights

Takegata is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to innovate and contribute to the field of pharmaceuticals. His work has not only advanced scientific understanding but has also paved the way for new therapeutic options in medicine.

Collaborations

Throughout his career, Takegata has collaborated with notable colleagues, including Satoru Nakai and Mayumi Kaneta. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Setsuko Takegata's contributions to the field of pharmaceuticals, particularly through his patents on IL-1.beta. and its derivatives, highlight his role as a leading inventor. His work continues to influence medical science and offers promising avenues for future research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…